XML 43 R33.htm IDEA: XBRL DOCUMENT
v3.23.1

PREFERRED AND COMMON STOCKHOLDERS' EQUITY (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Equity [Abstract] |
Schedule of Common Stock Issued and Outstanding | Shares of common stock issued and outstanding
| Three months ended March 31,
(in millions) | 2023 |  |  | 2022
Beginning common stock issued and outstanding | 81.2 |  |  |  | 80.0 |
Common stock issued upon exercise of options, vesting of restricted stock units, and purchases under employee stock purchase plan | 0.3 |  |  |  | 0.3 |
Common stock issued and outstanding at end of period | 81.5 |  |  |  | 80.3 |
Schedule of Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations | The following is a reconciliation of the denominators of the basic and diluted earnings per share (“EPS”) computations:
| Three months ended March 31, |  |
(in millions) | 2023 |  |  | 2022 |  |  |  |  |
Denominator: |  |  |  |  |  |  |  |  |
Weighted-average shares outstanding used to compute basic EPS | 81.3 |  |  |  | 80.1 |  |  |  |  |  |
Effect of dilutive shares | — |  |  |  | — |  |  |  |  |  |
Weighted-average shares outstanding and dilutive securities used to compute diluted EPS | 81.3 |  |  |  | 80.1 |  |  |  |  |  |
Schedule of Potential Dilutive Common Shares | These potential dilutive shares of common stock, which may be dilutive to future diluted earnings per share, are as follows:
| Three months ended March 31, |  |
(in millions) | 2023 |  |  | 2022 |  |  |  |  |
Anti-dilutive options and RSUs excluded from EPS computation | 5.6 |  |  |  | 5.5 |  |  |  |  |  |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in common stock outstanding. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration